Mark Howard Snyder - SVP, CHIEF LEGAL OFFICER at HALOZYME THERAPEUTICS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Chief Legal Officer
Issuer Symbol
HALO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Howard Snyder since 03 Mar 2025

Holdings reported by Mark Howard Snyder for HALOZYME THERAPEUTICS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 47,610 $3,363,170 $70.64 23 Feb 2026 Direct
Restricted Stock Units 14,022 $1,214,656 $57.75 23 Feb 2026 Direct Common Stock
Option to Purchase Common Stock 18,730 $313,504 $13.87 09 Feb 2026 Direct Common Stock
Performance Stock Units 0 $0 $58.29 16 Feb 2026 Direct Common Stock

Transactions reported by Mark Howard Snyder for HALOZYME THERAPEUTICS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.